Aptar Pharma Acquires PULMOTREE To Expand Pulmonary Drug Delivery Platform
· pulse2.com · popularity 21/100 · 0 similar stories today · Entrepreneurship & Startups (Business & Finance)
Read the original at pulse2.com →
Summary
Aptar Pharma has acquired PULMOTREE, a Munich-based life sciences company focused on pulmonary drug delivery technologies, expanding its respiratory product portfolio with a non-propellant liquid inhaler platform. The post Aptar Pharma Acquires PULMOTREE To Expand Pulmonary Drug Delivery Platform appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 2.